Abstract
Most of the previous studies dealing with the effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on the synthesis of inflammatory mediators involved in joint damage have been done in cells culturedin vitro or in blood cells from patients treated for short periods of time. In this work we have evaluated the long-term effect of aceclofenac, a new NSAID, and diclofenac on the production of a series of inflammatory mediators by blood cells from 30 patients with severe knee osteoarthritis. Both aceclofenac and diclofenac significantly inhibited prostaglandin E2 (PGE2) synthesis by blood mononuclear and polymorphonuclear cells after 180 days of treatment. However, no clear effect was noted on leukotriene B4 (LTB4) and platelet activating factor (PAF) production. The generation of O −2 by polymorphonuclear cells, stimulated with FMLP, was decreased after 15 days of treatment with both drugs, but reached normal values after 180 days. Interleukin-1β (IL-1β) production decreased significantly at 180 days with both drugs in the group of high producer patients. In a few (n=3) patients with high basal mononuclear cell tumor necrosis factor α (TNFα) production, this also decreased on treatment for 180 days with the NSAIDs. In the remaining low TNFα-producing patients, TNFα production tended to increase. Interleukin-6 (IL-6) synthesis was not affected by aceclofenac while it was diminished by diclofenac. The decrease in IL-6 in all treated patients was significantly correlated with a worsening of the clinical condition. On the whole, these data could afford a pathogenetic basic for the long-term employment of these drugs in patients with inflammatory conditions.
Similar content being viewed by others
References
J. R. Vane,Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature231, 232–235 (1971).
S. B. Abramson and G. Weissmann,The mechanism of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum.32, 1–9 (1989).
S. B. Abramson, B. Cherksey, D. Gude, J. Leszczynska-Piziak, M. R. Philips, L. Blau and G. Weissmann,Nonsteroidal antiinflammatory drugs exert differential effects on neutrophil function and plasma membrane viscosity. Studies in human neutrophils and liposomes. Inflammation14, 11–30 (1990).
G. Lozanski, S. P. Ballou and I. Kushner,Effect of flurbiprofen on cytokine production by human monocytes and U-937 and THP-1 cell lines. J. Rheumatol.19, 921–926 (1992).
Grupo de estudio de gonartrosis,Eficacia y tolerancia de aceclofenaco en el tratamiento de la gonartrosis. Rev. Esp. Reumatol.19, 142–146 (1992).
M. Grau, M. Guasch, J. L. Montero, A. Felipe, E. Carrasco and S. Julia,Pharmacology of a potent new nonsteroidal antiinflammatory agent: Aceclofenac. Arz. Forsch. Drug12, 1265–1276 (1991).
World Health Organization Regional Office for Europe,European League Against Rheumatisms (EULAR). Guidelines for the clinical investigation drugs used in rheumatic diseases. InEuropean Drug Guidelines series 5, final version, final version, Copenhagen, March 1985.
P. M. Henson, H. B. Johnson and H. L. Spiegelberg,The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses. J. Immunol.109, 1182–1187 (1972).
G. Herrero-Beaumont, J. Egido, J. Sancho, E. González, S. Castañeda and F. J. Escanero,Defective function of the mononuclear phagocytic system in rats with chronic nephritis. Evidence of a decreased degradation of IgG aggregates by Kupffer cells. Immunology63, 87–92 (1988).
W. S. Powell,Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol.86, 467–477 (1982).
L. H. Sisson, S. M. Prescot, T. M. McIntyre and G. A. Zimmerman,Production of platelet activating factor by stimulated human polymorphonuclear leucocytes. Correlation of synthesis with release, functional events and leucotriene B4 metabolism. J. Immunol.138, 3918–3926 (1987).
E. C. Bligh and W. J. Dyer,A rapid method of total lipid extraction and purification. J. Biochem. Physiol.37 911–917 (1959).
M. Sanchez-Crespo, F. Alonso and J. Egido,Platelet activating factor in anaphylaxis and phagocyosis. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A 23187 and phagocytosis but not from degranulating basophils. Immunology40, 645–655 (1980).
J. Benveniste, J. P. Le Coudic, J. Polonski and M. Tence,Structural analysis of purified platelet activating factor by lipases. Nature (Lond.)269, 170–171 (1977).
M. L. Blank and F. Snyder,Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids. J. Chromatogr.273, 415–420 (1983).
B. M. Babior, R. S. Kipnes and J. T. Curnutte,Biological defense mechanism: The production by leucocytes of superoxide, a potential bactericidal agent. J. Clin. Invest.52, 741–744 (1973).
A. P. Wilson,Cytotoxicity and viability assays. InAnimal Cell Celure. (Ed. R. I. Freshney) pp. 183–216, IRL Press, Oxford 1986.
J. A. Salmon and G. A. Higgs,Prostaglandins and leukotrienes as inflammatory mediators. Br. Med. Bull.43, 285–296 (1987).
E. Henderson, M. Grootveld and D. Blake,Origins of free radical mediated damage in the inflamed joint. Eur. J. Rheumatol Inflamm.11, 27–35 (1991).
J. Vilcek and T. H. Lee,Tumour necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem.66, 7313–7316 (1991).
J. O. Minta and M. D. Williams,Some nonsteroidal antiinflammatory drugs inhibit the generation of superoxide anions by activated polymorphonuclears by blocking ligand receptor interactions. J. Rheumatol.12, 751–757 (1985).
H. D. Perez, F. Elfman and S. Marder,Meclofenamate sodium monohydrate inhibits chemotactic factor induced human polymorphonuclear leucocyte function: A possible explanation for its antiinflammatory effect. Arthritis Rheum.30, 1023–1031 (1987).
K. Katayama, H. Shirota, S. Kobayashi, K. Terato, H. Ikuta and I. Yamatsu,In vitro effect of N-methoxy-3,2,2-Pyrrolidone (E5110), a novel nonsteroidal antiinflammatory agent, on generation of some inflammatory mediators. Agents Actions21, 269–271 (1987).
R. E. Crowell and D. E. Van Epps,Nonsteroidal antiinflammatory agents inhibit upregulation of CD11b, CD11c, and CD35 in neutrophils stimulated by formyl methionine leucine phenylalanine. Inflammation14, 163–170 (1990).
C. Kitoyaki and B. R. Bloom,Activation of murine macrophage cell lines. Possible involvement of protein kinases in stimulation of superoxide production. J. Immunol.133, 923–931 (1984).
B. A. M. Walker, B. E. Hagenlocker, E. B. Stubbs, R. R. Sandborg, B. W. Agranoff and P. A. Ward,Signal transduction events and FcR engagement in human neutrophils stimulated with immune complexes. J. Immunol.146, 735–741 (1991).
M. F. Fitzgerald, L. Parente and B. J. Whittle,Release of PAF-acether and eicosanoids from guinea pig alveolar macrophages by FMLP: Effect of cyclo-oxygenase and lipoxygenase inhibition. Eur. J. Pharmacol.164, 539–546 (1989).
P. Braquet and M. Rola-Pleszczynski,Platelet activating factor and cellular immune responses. Immunol. Today8, 345–352 (1987).
P. Zarco, C. Maestre, G. Herrero-Beaumont, E. Gonzãlez, R. Garcia-Hoyo, F. J. Navarro, P. Braquet and J. Egido,Involvement of platelet activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits. Clin. Exp. Immunol.88, 318–323 (1992).
A. Dulioust, E. Vivier, N. Meslier, R. Roubin, I. Haye-Legrand and J. Benveniste,Biosynthesis of PAF-acether. PAF-acether but not leukotriene C4 production is impaired in cultured macrophages. Biochem. J.263, 165–171 (1989).
N. Feldman, F. M. Brennan, D. Chantry, C. Haworth, M. Turner, E. Abney, G. Buchan, K. Barret, A. Chu, M. Field and R. N. Maini,Cytokine production in the rheumatoid joint: Implications for treatment. Ann. Rheum. Dis.49, 480–486 (1990).
R. Schindler, J. Mancilla, S. Endres, R. Ghorbani, S. C. Clark and C. A. Dinarello,Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumour necrosis factor (TNF) in human mononuclear cells. IL-6 suppresses IL-1 and TNF. Blood75, 40–47 (1990).
S. Endres, J. G. Cannon, R. Ghorbani, R. A. Dempsey, S. D. Sisson, G. Lonnemann, Van der Meer, S. M. Wolf and C. A. Dinarello,In vitro production of IL-1β, IL-1α, TNF and IL-2 in healthy subjects: Distribution, effect of CO inhibition and evidence of independent gene regulation. Eur. J. Immunol.19, 2327–2333 (1989).
D. M. Chang, P. Baptiste and P. H. Schur,The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 inhibitor production by human monocytes. J. Rheumatol.17, 1148–1157 (1990).
J. H. Herman, W. G. Sowder and E. H. Hess,NSAID induction of interleukin-1/catabolin inhibitor production by osteoarthritic synovial tissue. J. Rheumatol.27 (Suppl.), 124–126 (1991).
J. D. Sipe, L. M. Bartle and L. D. Loose,Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. J. Immunol.148, 480–484 (1992).
B. Hauptmann, J. Van Damme and J. M. Dayer,Modulation of IL-1 inflammatory and immunomodulatory properties by IL-6. Eur. Cytokine Netw2, 39–46 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
González, E., de la Cruz, C., de Nicolás, R. et al. Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents and Actions 41, 171–178 (1994). https://doi.org/10.1007/BF02001912
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02001912